sof_logo

Papers written by Dr. Ogita on lymphatic malformations

  1. Ogita S., Tsuto T., Tokiwa K., Takahashi T.: Intracystc injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Brit J Surg 74:690-691,1987.
  2. Ogita S., Tsuto T., Tokiwa K., Takahashi T.: Treatment of cystic hygroma in children with special reference to OK-432 therapy. Z Kinderchir 42:279-281,1987.
  3. Tsuto T., Tokiwa K., Ogita S., Takahashi T.: OK-432 injection therapy for cystic hygroma. J Jpn Soc Pediatr Surg 23:865-868, 1987. (in Japanese, abstract English)
  4. Ogita S., Tsuto T., Deguchi E., Tokiwa K., Takahashi T.: Giant Cavernous haemangioma: Treatment with intralesional injection of OK-432. Z Kinderchir 43:408-409,1988.
  5. Ogita S., Tsuto T., Deguchi E., Tokiwa K., Takahashi T.: Intralesional OK-432 therapy secondary to failure of initial surgery or Bleomycin therapy for lymphangioma in children. Jpn J Pediatr Surg 20:1515-1519, 1988. (in Japanese, abstract English)
  6. Ogita S., Tsuto T., Deguchi E., Tokiwa K., Yanagihara J., Iwai N.: An evalution of therapeutic results of lymphangiomas in children. J Jpn Soc Pediatr Surg 25:260-264, 1989. (in Japanese, abstract English)
  7. Ogita S., Tsuto T., Deguchi E., Tokiwa K., Yanagihara J., Iwai N.: Treatment of lymphangiomas arising around cervico-facial region: surgery, Bleomycin, therapy and OK-432 therapy. J Jpn Surg Soc 90:1389-1391,1989.(in Japanese, abstract English)
  8. Ogita S., Tsuto T., Deguchi E., Tokiwa K., Nagashima M., Iwai N.: OK-432 therapy for unresectable lymphangiomas in children. J Pediatr Surg 26:263-270,1991.
  9. Tsuchihashi Y., Ogita S.: Histopathological study of the effect of OK-432 on lymphangioma of an infant. J Kyoto Pref Univ Med 102:1055-1060,1993.
  10. Ogita S., Tsuto T., Nakamura K., Deguchi E., Iwai N.: OK-432 therapy for cystic hygroma and cavernous lymphangioma. Jpn J Pediatr Surg 24:371-376,1993. (in Japanese, abstract English)
  11. Ogita S., Iwai N.: Treatment of lymphangioma: Surgery, Intralesional Bleomycin therapy and/or OK-432 therapy. Jpn J Pediatr Surg 25:631-635,1993. (in Japanese, abstract English)
  12. Ogita S., Tsuto T., Nakamura K., Deguchi E., Iwai N.: OK-432 therapy in 64 patients with lymphangioma. J Pediatr Surg 29:784-765,1994.
  13. Ogita S., Tsunoda A., Okabe I., Hashizume K.: Phase II study on OK-432 therapy for lymphangiomas in children. Ther Res 15:3285-3297,1994. (in Japanese, abstract English)
  14. Ogita S., Tsunoda A., Okabe I., Hashizume K.: Phase III study on OK-432 therapy for lymphangiomas in children. J Jpn Soc Pediatr Surg 31:29-36,1995. (in Japanese, abstract English)
  15. Ogita S., Tsuto T., Nakamura K., Deguchi E., Tokiwa K., Iwai N.:OK-432 therapy for lymphangioma in children: Why and how does it work? J Pediatr Surg 31:477-480,1996
  16. Ogita S., Deguchi E., Tokiwa K., Iwata J., Kubota Y., Iwai N.: Ongoing osteolysis in patients with lymphangioma. J Pediatr Surg 33:45-48,1998.
  17. Ogita S., Higuchi K., Kimura O., Shimotake E., Deguchi E., Iwai N.: Terapia con OK-432 en linfangiomas de lengua. Rev.de Cir Infantil 8:145-148,1998. (abstract English)
  18. Ogita S.: OK-432 therapy for lymphangiona. J Jpn Soc Pediatr Radiol 15:25-31,1999. (in Japanese, abstract English)
  19. Ogita S.: Intralesional injection of OK-432 in percutaneus treatment for lymphangiona. J Jpn Soc Pediatr Radiol 17:78-84,2001. (in Japanese, abstract English)
  20. Ogita S.: Intralesional injection therapy for lymphangiona in children. Jpn J Periatr Surg 34:125-130,2002. (in Japanese, abstract English)

Back to top